Comparison Chart Entrada Therapeutics, Inc.

Stocks

TRDA

US29384C1080

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 12:24:57 2026-08-28 EDT			5-day change	1st Jan Change
6.995 ^USD	-3.78%		-7.66%	-32.00%

08-05	Entrada Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-03	Entrada Therapeutics Insider Sold Shares Worth $807,027, According to a Recent SEC Filing	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	ENTRADA THERAPEUTICS, INC.	Bio Therapeutic Drugs	-3.85%	-7.66%	-32.00%	+23.72%	-	262M